Morten Frisch

Morten Frisch

Auto-generated profile, based on publicly available information

Morten Frisch

Project SEXUS Group, Section of Blood‐borne and Sexually Transmitted Infections & Digitization of Infectious Disease Surveillance, Department of Infectious Disease Epidemiology and Prevention Statens Serum Institut Copenhagen Denmark

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 September 2000 in JNCI: Journal of the National Cancer Institute
Verified
Journal Article
Open access
PDF file
MFMorten Frisch
Morten Frisch
RBRobert J. Biggar
Robert J. Biggar
JGJames J. Goedert
James J. Goedert
Background: Human papillomavirus (HPV)-associated anogenital malignancies occur frequently in patients with human immunodeficiency virus (HIV) infection and the acquired immunodeficiency syndrome (AIDS). The purpose of our study was to determine if the high frequency of these cancers is due to lifestyle factors associated with both HPV and HIV infections or to immunosuppression following HIV infection. Methods: We studied invasive and in situ HPV-associated cancers among 309 365 U.S. patients with HIV infection/AIDS (257 605 males and 51 760 females) from 5 years before the date of AIDS onset to 5 years after this date. Sex-, race-, and age-standardized ratios of observed-to-expected cancers served as measures of relative risk (RR). Trend tests were used to evaluate changes in the RRs during the 10 years spanning AIDS onset. All statistical tests were two-sided. Results: All HPV-associated cancers in AIDS patients occurred in statistically significant excess compared with the expected numbers of cancers. For in situ cancers, overall risks were significantly increased for cervical (RR = 4.6; 95% confidence interval [CI] = 4.3–5.0), vulvar/vaginal (RR = 3.9; 95% CI = 2.0–7.0), anal (in females, RR = 7.8 [95% CI = 0.2–43.6]; in males, RR = 60.1 [95% CI = 49.2–72.7]), and penile (RR = 6.9; 95% CI = 4.2–10.6) cancers, and RRs increased during the 10 years spanning AIDS onset for carcinomas in situ of the cervix (P for trend <.001), vulva/vagina (P for trend = .04), and penis (P for trend = .04). For invasive cancers, overall risks were significantly increased for cervical (RR = 5.4; 95% CI = 3.9–7.2), vulvar/vaginal (RR = 5.8; 95% CI = 3.0–10.2), and anal (RR = 6.8; 95% CI = 2.7–14.0) cancers in females and for anal (RR = 37.9; 95% CI = 33.0–43.4), penile (RR = 3.7; 95% CI = 2.0–6.2), tonsillar (RR = 2.6; 95% CI = 1.8–3.8), and conjunctival (RR = 14.6; 95% CI = 5.8–30.0) cancers in males. However, RRs for invasive cancers changed little during the 10 years spanning AIDS onset. Conclusions: HPV-associated malignancies occur at increased rates in persons with HIV/AIDS. Increasing RRs for in situ cancers to and beyond the time of AIDS onset may reflect the gradual loss of control over HPV-infected keratinocytes with advancing immunosuppression. However, the lack of a similar increase for invasive HPV-associated cancers suggests that late-stage cancer invasion is not greatly influenced by immune status.

4 April 2001 in JAMA
Verified
Journal Article
Open access
PDF file
MFM Frisch
M Frisch
RBR J Biggar
R J Biggar
EEE A Engels
E A Engels
JGJ J Goedert
J J Goedert
AGAIDS-Cancer Match Registry Study Group
AIDS-Cancer Match Registry Study Group
Immunosuppression associated with human immunodeficiency virus (HIV) infection and the acquired immunodeficiency syndrome (AIDS) markedly increases the risk of Kaposi sarcoma (KS) and non-Hodgkin lymphoma (NHL).1 These malignancies and invasive cervical cancer are the only AIDS-defining cancers in HIV-infected individuals.2 Other specific cancers also occur in excess, but the risk pattern depends on the geographic region and the HIV exposure group studied.3,4 In industrialized parts of the world, a high level of risk has been found for anal cancer5 and Hodgkin disease,6-8 and marginally significant increases were reported for seminoma, multiple myeloma, and brain cancer.7,8 We used data from the recently updated AIDS-Cancer Match Registry Study to investigate the cancer pattern in the years surrounding the time of AIDS diagnosis among 302 834 adult persons with HIV/AIDS (PWAs) in the United States. Specifically, we aimed at identifying cancers that are likely to be influenced by immunosuppression, distinguishing them from those occurring in excess among PWAs due to lifestyle-related exposures linked to cancer risk independently of immunosuppression.

6 November 1997 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
MFMorten Frisch
Morten Frisch
BGBengt Glimelius
Bengt Glimelius
ABAdriaan J.C. van Den Brule
Adriaan J.C. van Den Brule
JWJan Wohlfahrt
Jan Wohlfahrt
CMChris J.L.M. Meijer
Chris J.L.M. Meijer
MMMads Melbye
Mads Melbye
The incidence of anal cancer has increased in recent decades, particularly among women. To identify underlying risk factors, we conducted a population-based case–control study in Denmark and Sweden. We conducted telephone interviews with 324 women and 93 men in whom invasive or in situ anal cancer was diagnosed between 1991 and 1994, 534 controls with adenocarcinoma of the rectum, and 554 population controls. The interviews covered a wide spectrum of possible risk factors for anal cancer. Odds ratios were calculated by logistic regression. Specimens of anal-cancer tissue and samples of rectal adenocarcinomas were tested for human papillomavirus (HPV) DNA with the polymerase chain reaction. Multivariate analysis revealed consistent and statistically significant associations between measures of sexual promiscuity and the risk of anal cancer in both men and women. There was a significant trend toward an association between higher numbers of partners of the opposite sex in women (P<0.001) and men (P<0.05) and strong associations with a variety of venereal diseases. In women, receptive anal intercourse, particularly before the age of 30 years, and venereal infections in the partner were also associated with an increased risk (odds ratios, 3.4 and 2.4, respectively). Fifteen percent of the men with anal cancer reported having had homosexual contact, as compared with none of the controls (P<0.001). High-risk types of HPV, notably HPV-16, were detected in 84 percent of the anal-cancer specimens examined, whereas all rectal-adenocarcinoma specimens tested were negative for HPV. Our study provides strong evidence that a sexually transmitted infection causes anal cancer. The presence of high-risk types of HPV, notably HPV-16 (which is known to cause cancer of the cervix), in the majority of anal-cancer tissue specimens suggests that most anal cancers are potentially preventable. (N Engl J Med 1997;337;1350-8.)

21 October 2010 in Gut
Verified
Journal Article
Closed access
PDF file
AHAnders Hviid
Anders Hviid
HSHenrik Svanström
Henrik Svanström
MFMorten Frisch
Morten Frisch
Background The composition of the intestinal microflora has been proposed as an important factor in the development of inflammatory bowel diseases (IBD). Antibiotics have the potential to alter the composition of the intestinal microflora. A study was undertaken to evaluate the potential association between use of antibiotics and IBD in childhood. Methods A nationwide cohort study was conducted of all Danish singleton children born from 1995 to 2003 (N=577 627) with individual-level information on filled antibiotic prescriptions, IBD and potential confounding variables. Using Poisson regression, rate ratios (RRs) of IBD were calculated according to antibiotic use. Antibiotic use was classified according to time since use, type, number of courses used and age at use. Results IBD was diagnosed in 117 children during 3 173 117 person-years of follow-up. The RR of IBD was 1.84 (95% CI 1.08 to 3.15) for antibiotic users compared with non-users. This association appeared to be an effect on Crohn's disease (CD) alone (RR 3.41) and was strongest in the first 3 months following use (RR 4.43) and among children with ≥7 courses of antibiotics (RR 7.32). Conclusions Antibiotic use is common in childhood and its potential as an environmental risk factor for IBD warrants scrutiny. This is the first prospective study to show a strong association between antibiotic use and CD in childhood. However, as with any observational study, causality cannot be inferred from our results and confounding by indication—in particular, prescribing of antibiotics to children with intestinal symptoms of as yet undiagnosed CD—should also be considered as a possible explanation.

1 February 2002 in The Lancet
Verified
Journal Article
Open access
EEEric A Engels
Eric A Engels
MFMorten Frisch
Morten Frisch
JGJames J Goedert
James J Goedert
RBRobert J Biggar
Robert J Biggar
RMRobert W Miller
Robert W Miller
Merkel cell carcinoma (MCC) is a rare skin cancer that occurs more frequently after organ transplantation or B-cell malignancy, conditions of suppressed or disordered immunity. To assess further whether immune suppression increases MCC risk, we studied its occurrence in a cohort of 309365 individuals with acquired immunodeficiency syndrome (AIDS) by using linked AIDS and cancer registries. We identified six cases of MCC, corresponding to a relative risk of 13.4 (95% CI 4.9-29.1) compared with the general population. These results suggest that immune suppression induced by the human immunodeficiency virus increases MCC risk.

1 August 2012 in Gastroenterology
Verified
Journal Article
Closed access
TJTine Jess
Tine Jess
JSJacob Simonsen
Jacob Simonsen
KJKristian Tore Jørgensen
Kristian Tore Jørgensen
BPBo Vestergaard Pedersen
Bo Vestergaard Pedersen
NNNete Munk Nielsen
Nete Munk Nielsen
MFMorten Frisch
Morten Frisch